Test of a Preventive Effect of a Deodorant Device Against Respiratory Infections
Cleverin
Double-blind Sham Device-controlled Multi-center Crossover Trial of Chlorine Dioxide Gas on the Protective Effect Against Respiratory Infections
1 other identifier
interventional
1,469
1 country
1
Brief Summary
This study is to test whether a chlorine dioxide gas-generating device, which releases a low concentration gas of chlorine dioxide in a sustained manner, can protect against respiratory infections in elderly individuals living in nursing homes. Such a device is used as a deodorant for normal domestic purposes. The investigators reasoned that the antiviral and antibacterial properties of chlorine dioxide might lead to a lowering in the incidence of respiratory infectious diseases. The study is designed as a randomized placebo-controlled double-blind crossover multicentre trial involving approximately 1500 subjects.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Oct 2009
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 30, 2009
CompletedFirst Posted
Study publicly available on registry
September 1, 2009
CompletedStudy Start
First participant enrolled
October 1, 2009
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2010
CompletedStudy Completion
Last participant's last visit for all outcomes
April 1, 2010
CompletedFebruary 4, 2010
February 1, 2010
5 months
August 30, 2009
February 2, 2010
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
The number of incidence of respiratory infections
Four months
Secondary Outcomes (1)
The incidence of adverse effects
Four months
Study Arms (2)
Active Cleverin Gel
EXPERIMENTALActive Cleverin Gel, which generates chlorine dioxide gas, is placed in a room of subject.
Inactive Cleverin Gel
SHAM COMPARATORInactive Cleverin Gel is placed in a room of subject. It does not generate chlorine dioxide gas.
Interventions
Chlorine dioxide gas concentration at a range of 0.005 to 0.03 ppm.
Seemingly same chlorine dioxide gas-generating device, but no gas is generated.
Eligibility Criteria
You may qualify if:
- Those who who agrees with the aim of the study
You may not qualify if:
- Those who do not agree with the aim of the study
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Reifuen Nursing Home
Osaka, Osaka, 558-0054, Japan
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Norio Ogata, MD, PhD
Taiko Pharmaceutical Co., Ltd.
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, INVESTIGATOR
- Purpose
- PREVENTION
- Intervention Model
- CROSSOVER
- Sponsor Type
- INDUSTRY
Study Record Dates
First Submitted
August 30, 2009
First Posted
September 1, 2009
Study Start
October 1, 2009
Primary Completion
March 1, 2010
Study Completion
April 1, 2010
Last Updated
February 4, 2010
Record last verified: 2010-02